Eduarda Luza
Research Subjects
Research Interests
Eduarda Luza has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alessandra Galski Rosiak1 shared publication
- Daniel Wenceslau Votto Olmedo
Universidade Federal do Rio Grande, Brazil; Universidade Federal do Rio Grande, Brazil
1 shared publication - Daniela Fernandes Ramos
Universidade Federal do Rio Grande (FURG) – Faculdade de Medicina – Área Interdisciplinar em Ciências Biomédicas – Núcleo de Pesquisas em Microbiologia Médica, Rio Grande, Rio Grande do Sul, Brasil
1 shared publication - Dara Biatobock
Universidade Federal do Rio Grande - FURG, Brazil
1 shared publication - Karine Ortiz Sanchotene
Laboratório de Micologia (FAMED-FURG) , Rio Grande, RS 96200-200
1 shared publication - Linjie Zhang
Faculdade de Medicina Universidade Federal do Rio Grande ‐ FURG Rio Grande Brazil
1 shared publication
Latest Publications
- Open Access
- 11 February 2025
- Published by Associacao Medica do Parana in BioSCIENCE
- Vol. 83 (e)
Determining factors of non-fibrocystic bronchiectasis in patients from southern Brazil: pilot study
Introduction: Bronchiectasis is a chronic respiratory disease that is largely related to inflammatory processes, irreversible dilation of the bronchi and the presence of recurrent lung infections. Furthermore, the disease presents a wide geographic, prevalence and etiological variability, driving the need for local assessments that aim to understand the disease and its behavior in different regions of the world. Objective: To carry out a first approach to the prevalence profile of the disease in the extreme south of Brazil. Method: Census study evaluating the clinical, sociodemographic profile and prevalence of bronchiectasis in patients treated at a regional reference pulmonology outpatient clinic. Result: Of the 95 patients eligible for the study, 21 were classified as bronchiectatic through tomographic diagnosis. The majority of patients were women (67%), caucasian (86%), and aged between 61 and 80 years (62%). Regarding the diseases and symptoms reported by patients, a considerable presence of post-tuberculosis patients (40%) could be identified. Furthermore, the performance of pneumococcal vaccination was also a variable that showed a significant difference, where 55% of diagnosed patients did not undergo vaccination. Conclusion: This study allows the development of a population-based study, guiding health policies that favor the monitoring and quality of life of these patients
- 11 February 2025
- Published by Associacao Medica do Parana in BioSCIENCE
- Vol. 83 (e)
Open AccessDetermining factors of non-fibrocystic bronchiectasis in patients from southern Brazil: pilot study
Introduction: Bronchiectasis is a chronic respiratory disease that is largely related to inflammatory processes, irreversible dilation of the bronchi and the presence of recurrent lung infections. Furthermore, the disease presents a wide geographic, prevalence and etiological variability, driving the need for local assessments that aim to understand the disease and its behavior in different regions of the world. Objective: To carry out a first approach to the prevalence profile of the disease in the extreme south of Brazil. Method: Census study evaluating the clinical, sociodemographic profile and prevalence of bronchiectasis in patients treated at a regional reference pulmonology outpatient clinic. Result: Of the 95 patients eligible for the study, 21 were classified as bronchiectatic through tomographic diagnosis. The majority of patients were women (67%), caucasian (86%), and aged between 61 and 80 years (62%). Regarding the diseases and symptoms reported by patients, a considerable presence of post-tuberculosis patients (40%) could be identified. Furthermore, the performance of pneumococcal vaccination was also a variable that showed a significant difference, where 55% of diagnosed patients did not undergo vaccination. Conclusion: This study allows the development of a population-based study, guiding health policies that favor the monitoring and quality of life of these patients